118
Views
13
CrossRef citations to date
0
Altmetric
Review

The emerging role of molecular imaging and targeted therapeutics in peritoneal carcinomatosis

, & , MD
Pages 389-402 | Published online: 07 Aug 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cristina L. Zavaleta, Beth A. Goins, Ande Bao, Linda M. Mcmanus, C. Alex Mcmahan & William T. Phillips. (2008) Imaging of 186Re-liposome therapy in ovarian cancer xenograft model of peritoneal carcinomatosis. Journal of Drug Targeting 16:7-8, pages 626-637.
Read now

Articles from other publishers (12)

Pieterjan Debie, Chrystel Lafont, Michel Defrise, Inge Hansen, Danny M. van Willigen, Fijs W.B. van Leeuwen, Rik Gijsbers, Matthias D'Huyvetter, Nick Devoogdt, Tony Lahoutte, Patrice Mollard & Sophie Hernot. (2020) Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours. Journal of Controlled Release 317, pages 34-42.
Crossref
Muhammad Qutayba Almerie, Gemma Gossedge, Kathleen E. Wright & David G. Jayne. (2015) Photodynamic diagnosis for detection of peritoneal carcinomatosis. Journal of Surgical Research 195:1, pages 175-187.
Crossref
Cheol Moon, Eun Jung Kim, Dan Bee Choi, Byoung Soo Kim, Sa Hyun Kim & Tae Hyun Choi. (2015) The Characterization of Anti-HER-2/neu Monoclonal Antibody using Different in vivo Imaging Techniques. Biomedical Science Letters 21:1, pages 23-31.
Crossref
Christof SeidlMarkus Essler. (2013) Radioimmunotherapy for peritoneal cancers. Immunotherapy 5:4, pages 395-405.
Crossref
Marina-Portia Anthony & Pek-Lan Khong. 2013. Abdominal Imaging. Abdominal Imaging 1541 1562 .
Mario Vallon, Christof Seidl, Birgit Blechert, Zhoulei Li, Klaus-Peter Gilbertz, Anja Baumgart, Michaela Aichler, Annette Feuchtinger, Florian C. Gaertner, Frank Bruchertseifer, Alfred Morgenstern, Axel K. Walch, Reingard Senekowitsch-Schmidtke & Markus Essler. (2012) Enhanced efficacy of combined 213Bi-DTPA-F3 and paclitaxel therapy of peritoneal carcinomatosis is mediated by enhanced induction of apoptosis and G2/M phase arrest. European Journal of Nuclear Medicine and Molecular Imaging 39:12, pages 1886-1897.
Crossref
Christian Rauch, Christof Seidl, Martin Schlapschy, Arne Skerra, Alfred Morgenstern, Frank Bruchertseifer & Reingard Senekowitsch-Schmidtke. (2012) High molecular mass radioimmunoconjugates are promising for intraperitoneal α-emitter immunotherapy due to prolonged retention in the peritoneum. Nuclear Medicine and Biology 39:5, pages 617-627.
Crossref
Rajan Rakheja, William Makis & Marc Hickeson. (2011) Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT. Abdominal Imaging 37:2, pages 304-308.
Crossref
Christof Seidl & Reingard Senekowitsch-Schmidtke. 2014. Therapeutic Nuclear Medicine. Therapeutic Nuclear Medicine 557 567 .
Celeste Aida S. Regino, Mikako Ogawa, Raphael Alford, Karen J. Wong, Noboyuki Kosaka, Mark Williams, Brian J. Feild, Masatoshi Takahashi, Peter L. Choyke & Hisataka Kobayashi. (2010) Two-Step Synthesis of Galactosylated Human Serum Albumin as a Targeted Optical Imaging Agent for Peritoneal Carcinomatosis. Journal of Medicinal Chemistry 53:4, pages 1579-1586.
Crossref
Enken Drecoll, Florian C. Gaertner, Matthias Miederer, Birgit Blechert, Mario Vallon, Jan M. Müller, Andrea Alke, Christof Seidl, Frank Bruchertseifer, Alfred Morgenstern, Reingard Senekowitsch-Schmidtke & Markus Essler. (2009) Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213Bi-DTPA-[F3]2 into the Nucleus of Tumor Cells. PLoS ONE 4:5, pages e5715.
Crossref
Diane E. Milenic, Kayhan Garmestani, Erik D. Brady, Kwamena E. Baidoo, Paul S. Albert, Karen J. Wong, Joseph Flynn & Martin W. Brechbiel. (2008) Multimodality Therapy: Potentiation of High Linear Energy Transfer Radiation with Paclitaxel for the Treatment of Disseminated Peritoneal Disease. Clinical Cancer Research 14:16, pages 5108-5115.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.